0.00Open0.01Pre Close0 Volume354 Open Interest850.00Strike Price0.00Turnover2060.83%IV11.10%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0016Delta0.0002Gamma76510.00Leverage Ratio-68.0516Theta0.0000Rho121.98Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet